Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
暂无分享,去创建一个
S. Knapp | O. Fedorov | A. Bullock | V. Pogačić | J. Schwaller | P. Filippakopoulos | A. Biondi | S. Meyer-Monard | C. Gasser | S. Meyer‐Monard